Delivery Order SPE2DB22D3011-SPE2DB24FP9YG

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,955.99 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract, valued at $10,623.96, is a Firm Fixed Price Delivery Order that runs through April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025,...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract award, valued at $1,214.38, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award is for the delivery of 4,559,457,678 units of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,573.55 fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 28, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,635.20 and an ultimate completion date of December 7, 2022. The contract was awarded on December 6, 2022 and does not have a set-aside...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,130.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 14, 2022. Amerisourcebergen Drug Corp is an experienced pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The Firm Fixed Price Delivery Order has a ceiling value of $2,635.20 and an ultimate completion date of November 15, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,145.00 and an ultimate completion date of October 20, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $1,328.80 and an ultimate completion date of January 7, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,820.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,563,311,234 units of Oseltamivir Phosphate 75 mg capsules. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FP9YG
    Delivery Order

This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company.

The contract is a firm fixed price delivery order with a ceiling value of $1,703.80 and a performance period through March 19, 2024. It is not associated with any set-aside designations. Amerisourcebergen Drug Corp has received numerous awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This includes an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 6/17/24, 9:21 AM